Finance

Beta
Lists
OKUR:NASDAQ
Onkure Therapeutics Inc
$4.50
0.00%
(0.00) 1D
$4.50
0.00% (0.00)
After hours
Closed: Jun 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKUR...
Open
$4.54
High
$4.67
Low
$4.40
Mkt. cap
181.78M
Avg. vol.
443.33K
Volume
414.10K
52-wk high
$5.38
52-wk low
$1.91
EPS
-$4.33
Beta
0.28
Shares outstanding
40.40M
No. of employees
45
Open
$4.54
High
$4.67
Low
$4.40
Mkt. cap
181.78M
Avg. vol.
443.33K
Volume
414.10K
52-wk high
$5.38
52-wk low
$1.91
EPS
-$4.33
Beta
0.28
Shares outstanding
40.40M
No. of employees
45
News stories
From sources across the web
About Onkure Therapeutics Inc
CEO-
Employees45
Founded2011
HeadquartersBoulder, Colorado, United States
SectorBiotechnology
Websiteonkuretherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to OKUR in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OKUR in the last 3 months.
Highest
Current $4.50
$30.00 (+566.67%)
Average
$23.00 (+411.11%)
Lowest
$16.00 (+255.56%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leland Gershell
Oppenheimer
Buy
Maintained
$30.00
+566.7%
06/24/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
$16.00
+255.6%
05/09/2026
Boris Peaker
JonesTrading
Hold
Downgraded
-
-
05/06/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
$30.00
+566.7%
05/06/2026
Soumit Roy
JonesTrading
Buy
Maintained
$17.00
+277.8%
04/06/2026
Robert Burns
H.C. Wainwright
Buy
Maintained
$27.00
+500%
03/16/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
12.61M
11.92M
10.72M
11.71M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.71M
3.59M
3.40M
3.91M
Operating expense
16.32M
15.50M
14.12M
15.62M
Total operating expenses
16.32M
15.50M
14.12M
15.62M
Operating income
-16.32M
-15.50M
-14.12M
-15.62M
Other non operating income
-
-
-
-
EBT including unusual items
-15.39M
-14.70M
-13.50M
-15.16M
EBT excluding unusual items
-15.39M
-14.70M
-13.50M
-15.16M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15.39M
-14.70M
-13.50M
-15.16M
Net profit margin
-
-
-
-
Earnings per share
-1.14
-1.09
-0.99
-1.11
Interest and investment income
934.00K
804.00K
628.00K
458.00K
Interest expense
-
-2.00K
-6.00K
-
Net interest expenses
934.00K
802.00K
622.00K
458.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.21M
-15.39M
-14.02M
-15.51M
Gain or loss from assets sale
-
2.00K
4.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer